GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline.
GSK already owned a stake in GlycoVaxyn and had been working with the company since 2012 on the development of conjugate vaccines for bacterial infections.
How are venture capital dollars are actually disseminated? Into early stage companies? Late? What fields get the most investment – cancer?
Bruce Booth of Atlas Ventures blogged about this today on his Life Sci VC site about this topic, highlighted in a new whitepaper from BIO. Here are the highlights:
District regulators approved the city’s first equity crowdfunding campaign last week. It was also the only application they’ve received to date.
The Department of Insurance, Securities and Banking approved equity crowdfunding rules last October as a way for the city’s entrepreneurs to raise small sums of money from city residents in exchange for a piece of their business.
Swiss cancer drugs giant Roche (ROG: SIX) has acquired Signature Diagnostics, a privately-held company based in Potsdam, Germany. Financial terms of the transaction, which is the fifth deal in the past year aimed at building Roche’s molecular diagnostics business, were not disclosed.
Google is altering the way it displays search results. Over the next few days, Google Search will begin to dish out health bits of facts with search news. This is Google’s new attempt at health news, in fact, this could be a way to reimagine the now defunct Google Health.
This is not a first for Google. Its feet are firmly planted in the health space, having previously launched feature where people can connect to a doctor via video and its .
It takes just one idea to change the world
The EY Entrepreneur Of The Year™ Award has become the mark of world-class individuals leading world-class companies. We invite you to be part of this exciting program.
About the Entrepreneur Of The Year Program
EY Entrepreneur Of The Year honors entrepreneurs whose ingenuity, hard work and perseverance have created and sustained successful, growing business ventures. The program is celebrating its 29th year and has expanded to more than 140 cities and 50 countries around the world. EY forms a group of individuals from the business community to participate as the independent panel of judges for the program. This panel is made up of past award winners and C-suite leadership of high-growth entrepreneurial organizations. It also includes influential business leaders from the venture capital and private equity communities.
The recent February issue of Health Affairs, which features a series of articles on innovation, provides us with an opportunity to examine the state of America’s innovation ecosystem for medical technology. This ecosystem has produced a myriad of medical advances, ranging from advanced imaging to molecular diagnostics, minimally invasive surgical tools, and incredibly sophisticated implants. These technologies have shortened hospital stays, reduced the economic burden of disease, and saved and improved millions of lives.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
Please note that most links to RFAs, PAs, and Guide Notices will take you to the NIH Web site. RFPs will take you to FedBizOpps. Links to RFPs will not work past their proposal receipt date. Archived versions of RFPs posted on FedBizOpps can be found on the FedBizOpps site using the FedBizOpps search function. Under “Document to Search,” select Archived Documents.
Crowdfunding is a hot idea in small biopharma, but a lot of people don’t quite know what to make of it. I’ve written about some academic examples of it, and I think that’s a good use of the idea. People can donate in the expectation that they’re helping along a research project, not because they’re looking for a big return on their money.
The NFL, GE, and Under Armour officials announced that they have joined with the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) to launch Head Health Challenge III, an open innovation competition to advance materials that better absorb or dissipate energy. These new materials could improve the performance of protective equipment for athletes, military personnel and those in dangerous occupations.
